Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedNew location listings were added across multiple countries and regions, and several existing locations were removed. A revision tag Revision: v3.3.3 is shown.SummaryDifference2%

- Check55 days agoChange DetectedPublications section updated to note that items are automatically filled from PubMed, and the revision tag updated to v3.3.2.SummaryDifference0.1%

- Check62 days agoChange DetectedThe funding/update notice about potential data delays and NIH operations status has been removed from the page.SummaryDifference0.2%

- Check76 days agoChange DetectedAdded the RUXCOVID Lancet Rheumatol 2022 publication citation with full author list and DOI. Removed the Lancet Rheumatol 2024 erratum notice.SummaryDifference0.3%

- Check105 days agoChange DetectedUpdated citation (with erratum) and operating status notice added; older citation and earlier revision removed. The page now references the corrected citation version (v3.2.0) and includes current government operating status information.SummaryDifference3%

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.